Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 EUR | +0.25% | +1.02% | -13.70% |
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Genetically Modified Mouse, Rat and Cell Line Models
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 28/02/99 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 30/09/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 28/02/99 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Andre Tartar
BRD | Director/Board Member | - | - |
Director/Board Member | 59 | - | |
Robert Léon
BRD | Director/Board Member | 75 | 24/02/03 |
Laurent Fraisse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,046,590 | 6,566,389 ( 72.58 %) | 246,705 ( 2.727 %) | 72.58 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-13.70% | 38.19M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALGEN Stock
- Company genOway